Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,640.00
+120.00 (2.17%)
At close: Sep 11, 2026

Keeps Biopharma Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,54022,04418,7774,10623,62537,197
Short-Term Investments
6,6571,8793,934756.56303,092
Trading Asset Securities
10,7902,649276.086,0471,549600.6
Cash & Short-Term Investments
28,98726,57122,98810,91025,20340,889
Cash Growth
-35.39%15.59%110.71%-56.71%-38.36%28.98%
Accounts Receivable
32,89220,97916,2569,6776,1946,718
Other Receivables
-288.65460.571,925212.39332.01
Receivables
32,89221,26716,71613,2466,40712,850
Inventory
30,56031,52420,4365,3281,6022,246
Prepaid Expenses
-633.76828.01113.0653.642.96
Other Current Assets
14,67722,3869,74617,16910,0447,315
Total Current Assets
107,115102,38270,71446,76643,31063,342
Property, Plant & Equipment
46,10143,63635,06828,37610,06210,365
Long-Term Investments
9,42610,29715,1109,21618,36916,906
Goodwill
-29,51629,25023,970--
Other Intangible Assets
51,39921,90511,5146,596958.46965.41
Long-Term Accounts Receivable
---0129.69361.77
Long-Term Deferred Tax Assets
--312.111,528--
Other Long-Term Assets
19,84324,5735,021826.236,3671,462
Total Assets
233,884233,917166,989117,27985,55993,401

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9,7133,9155,9252,765630.13768.35
Accrued Expenses
-2,4321,9691,956744.98901.09
Short-Term Debt
25,70035,06641,64047,90428,12426,755
Current Portion of Long-Term Debt
32,0059,693330.72---
Current Portion of Leases
541.31333.82276.49308.59310.16276.52
Current Income Taxes Payable
599.16697.832,991---
Other Current Liabilities
32,08337,27132,6612,9462,2501,496
Total Current Liabilities
100,64289,40785,79355,88032,05930,197
Long-Term Debt
36,85547,34713,427---
Long-Term Leases
158.73153.6762.8591.93386.34571.69
Pension & Post-Retirement Benefits
787.01237.46424.77525.41--
Long-Term Deferred Tax Liabilities
4,8255,2322,526356.28248.32766.68
Other Long-Term Liabilities
10,97010,0371,3401,846597.55978.75
Total Liabilities
154,238152,415103,57458,69933,29132,514

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10,03910,0399,3749,3749,3749,268
Additional Paid-In Capital
61,66561,66536,80667,86667,69164,242
Retained Earnings
-5,617-2,4697,270-23,631-27,455-15,188
Comprehensive Income & Other
-3,528-7,224-3,3173,6273,4622,704
Total Common Equity
62,55962,01150,13457,23653,07261,026
Minority Interest
17,08819,49213,2821,343-804.49-139.37
Shareholders' Equity
79,64781,50363,41558,57952,26860,887
Total Liabilities & Equity
233,884233,917166,989117,27985,55993,401

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
95,26092,59355,73748,30428,82027,603
Net Cash (Debt)
-66,274-66,022-32,749-37,395-3,61713,286
Net Cash Growth
-----21.17%
Net Cash Per Share
-3316.13-3365.52-1735.34-1987.66-193.02767.26
Filing Date Shares Outstanding
20.0620.0818.7518.7518.7518.54
Total Common Shares Outstanding
20.0620.0818.7518.7518.7518.54
Working Capital
6,47312,974-15,079-9,11411,25133,145
Book Value Per Share
3119.313088.472673.993052.822830.713292.31
Tangible Book Value
11,16010,5909,37026,67152,11460,061
Tangible Book Value Per Share
556.47527.42499.751422.532779.593240.22
Land
-20,92313,66312,7103,0223,022
Buildings
-12,83816,94316,1906,9536,953
Machinery
-22,99720,99115,3123,3433,283
Construction In Progress
-5,3452,886---